ENPP3 and nonpapillary renal cell carcinoma: As previously discussed in this article, ENPP3 is highly expressed in ccRCC, making it a potential target in the development of ADCs.108 Two anti-ENPP3 targeting ADCs (AGS-16M8F, AGS-16C3F) were investigated in 2 phase 1 studies.